Literature DB >> 22898832

Down-regulation of A20 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Di Li1, Lei Wang, Yuchen Fan, Lijun Song, Chun Guo, Faliang Zhu, Lining Zhang, Yongyu Shi.   

Abstract

PURPOSE: A20 gene functions in negative immunoregulation and its SNP is related to SLE disease. But its expression level in immune cells from SLE patients is still unclear. The aim of this study is to investigate whether the expression of A20 is associated with pathogenesis of SLE.
METHODS: Real-time transcription-polymerase chain reaction analysis (RT-PCR) was used to determine expression of A20 mRNA in peripheral blood mononuclear cells (PBMC) from 37 patients with SLE and 32 healthy controls.
RESULTS: A20 expression was decreased in SLE patients compared with healthy controls (p = 0.0133). The expression level of A20 gene negatively correlated with the SLE disease activity index (SLEDAI) (r =-0.4661, p = 0.0036) and erythrocyte sedimentation rate (ESR) (r =-0.5222, p = 0.0009). Furthermore, SLE patients with nephritis had a lower expression of A20 than those without nephritis (p = 0.0188).
CONCLUSIONS: Our results suggest that the insufficient expression of A20 gene in PBMC may take part in the pathogenesis of SLE disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22898832     DOI: 10.1007/s10875-012-9764-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

Review 1.  A20: central gatekeeper in inflammation and immunity.

Authors:  Beatrice Coornaert; Isabelle Carpentier; Rudi Beyaert
Journal:  J Biol Chem       Date:  2008-11-13       Impact factor: 5.157

2.  A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies.

Authors:  Nadine Hövelmeyer; Sonja Reissig; Nguyen Thi Xuan; Petra Adams-Quack; Dominika Lukas; Alexei Nikolaev; Dirk Schlüter; Ari Waisman
Journal:  Eur J Immunol       Date:  2011-02-10       Impact factor: 5.532

3.  The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.

Authors:  Rita M Tavares; Emre E Turer; Chih L Liu; Rommel Advincula; Patrizia Scapini; Lesley Rhee; Julio Barrera; Clifford A Lowell; Paul J Utz; Barbara A Malynn; Averil Ma
Journal:  Immunity       Date:  2010-08-12       Impact factor: 31.745

4.  Cutting edge: TCR ligation triggers digital activation of NF-kappaB.

Authors:  Lara M Kingeter; Suman Paul; Sean K Maynard; Natalia G Cartwright; Brian C Schaefer
Journal:  J Immunol       Date:  2010-09-20       Impact factor: 5.422

5.  A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis.

Authors:  Mourad Matmati; Peggy Jacques; Jonathan Maelfait; Eveline Verheugen; Mirjam Kool; Mozes Sze; Lies Geboes; Els Louagie; Conor Mc Guire; Lars Vereecke; Yuanyuan Chu; Louis Boon; Steven Staelens; Patrick Matthys; Bart N Lambrecht; Marc Schmidt-Supprian; Manolis Pasparakis; Dirk Elewaut; Rudi Beyaert; Geert van Loo
Journal:  Nat Genet       Date:  2011-08-14       Impact factor: 38.330

6.  Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus.

Authors:  Indra Adrianto; Feng Wen; Amanda Templeton; Graham Wiley; Jarrod B King; Christopher J Lessard; Jared S Bates; Yanqing Hu; Jennifer A Kelly; Kenneth M Kaufman; Joel M Guthridge; Marta E Alarcón-Riquelme; Juan-Manuel Anaya; Sang-Cheol Bae; So-Young Bang; Susan A Boackle; Elizabeth E Brown; Michelle A Petri; Caroline Gallant; Rosalind Ramsey-Goldman; John D Reveille; Luis M Vila; Lindsey A Criswell; Jeffrey C Edberg; Barry I Freedman; Peter K Gregersen; Gary S Gilkeson; Chaim O Jacob; Judith A James; Diane L Kamen; Robert P Kimberly; Javier Martin; Joan T Merrill; Timothy B Niewold; So-Yeon Park; Bernardo A Pons-Estel; R Hal Scofield; Anne M Stevens; Betty P Tsao; Timothy J Vyse; Carl D Langefeld; John B Harley; Kathy L Moser; Carol F Webb; Mary Beth Humphrey; Courtney Gray Montgomery; Patrick M Gaffney
Journal:  Nat Genet       Date:  2011-02-20       Impact factor: 38.330

7.  Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.

Authors:  C K Wong; L C W Lit; L S Tam; E K Li; C W K Lam
Journal:  Rheumatology (Oxford)       Date:  2005-05-03       Impact factor: 7.580

8.  Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases.

Authors:  Minoru Fujimoto; Hiroko Tsutsui; Ouyang Xinshou; Masanori Tokumoto; Dai Watanabe; Yoshihito Shima; Tomohiro Yoshimoto; Hideki Hirakata; Ichiro Kawase; Kenji Nakanishi; Tadamitsu Kishimoto; Tetsuji Naka
Journal:  Int Immunol       Date:  2004-02       Impact factor: 4.823

9.  Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide.

Authors:  Antoni Hrycek; Dariusz Kusmierz; Tomasz Dybała; Longina Swiatkowska
Journal:  Autoimmunity       Date:  2007-02       Impact factor: 2.815

Review 10.  Inflammatory cytokines in systemic lupus erythematosus.

Authors:  Kim Ohl; Klaus Tenbrock
Journal:  J Biomed Biotechnol       Date:  2011-10-16
View more
  15 in total

1.  Tumor necrosis factor α-induced protein-3 protects zinc transporter 8 against proinflammatory cytokine-induced downregulation.

Authors:  Liqing Cheng; Dongmei Zhang; Bing Chen
Journal:  Exp Ther Med       Date:  2016-06-15       Impact factor: 2.447

2.  A20 Ameliorates Intracerebral Hemorrhage-Induced Inflammatory Injury by Regulating TRAF6 Polyubiquitination.

Authors:  Zhaoyou Meng; Ting Zhao; Kai Zhou; Qi Zhong; Yanchun Wang; Xiaoyi Xiong; Faxiang Wang; Yuanrui Yang; Wenyao Zhu; Juan Liu; Maofan Liao; Lirong Wu; Chunmei Duan; Jie Li; Qiuwen Gong; Liang Liu; Ao Xiong; Meihua Yang; Jian Wang; Qingwu Yang
Journal:  J Immunol       Date:  2016-12-16       Impact factor: 5.422

Review 3.  Roles of A20 in autoimmune diseases.

Authors:  Min Zhang; Ling-Long Peng; Ying Wang; Jian-Shu Wang; Jiao Liu; Meng-Meng Liu; Jia Hu; Bin Song; Hai-Bing Yang
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

4.  C/EBP β mRNA expression is upregulated and positively correlated with the expression of TNIP1/TNFAIP3 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  Tian Qian; Yan Chen; Xiaowei Shi; Jian Li; Fei Hao; Dongmei Zhang
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

5.  Altered TNFAIP3 mRNA expression in peripheral blood mononuclear cells from patients with rheumatoid arthritis.

Authors:  Zhaoyan Wang; Zongliang Zhang; Jiangshui Yuan; L I Li
Journal:  Biomed Rep       Date:  2015-06-30

6.  Let-7 miRNAs Modulate the Activation of NF-κB by Targeting TNFAIP3 and Are Involved in the Pathogenesis of Lupus Nephritis.

Authors:  Jun Liu; Lin Zhu; Guang-liang Xie; Jing-fang Bao; Qing Yu
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

Review 7.  γδ T Cell-Mediated Immune Responses in Disease and Therapy.

Authors:  T Sree Latha; Madhava C Reddy; Prasad V R Durbaka; Aparna Rachamallu; Reddanna Pallu; Dakshayani Lomada
Journal:  Front Immunol       Date:  2014-11-10       Impact factor: 7.561

8.  Altered expression of A20 gene in peripheral blood mononuclear cells is associated with the progression of chronic hepatitis B virus infection.

Authors:  Yu-Chen Fan; Yuan-Yuan Zhang; Yan-Yan Sun; Na Wang; Xiao-Yan Xiao; Kai Wang
Journal:  Oncotarget       Date:  2016-10-18

9.  A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator.

Authors:  Swati Bhattacharyya; Wenxia Wang; Lauren Van Duyn Graham; John Varga
Journal:  Arthritis Res Ther       Date:  2016-10-03       Impact factor: 5.156

10.  Increased A20 mRNA Level in Peripheral Blood Mononuclear Cells is Associated With Immune Phases of Patients With Chronic Hepatitis B.

Authors:  Yan-Yan Sun; Yu-Chen Fan; Na Wang; Harry Hua-Xiang Xia; Xiao-Yan Xiao; Kai Wang
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.